CORZZ - Core Scientific, I... Stock Analysis | Stock Taper
Logo
Core Scientific, Inc. Tranche 2 Warrants

CORZZ

Core Scientific, Inc. Tranche 2 Warrants NASDAQ
$16.63 0.06% (+0.01)

Market Cap $5.15 B
52w High $17.14
52w Low $16.17
P/E 0
Volume 4.41K
Outstanding Shares 310.15M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $81.1M $69.22M $-146.66M -180.83% $-0.46 $-127.46M
Q2-2025 $78.63M $31.31M $-936.8M -1.19K% $-0.04 $-634K
Q1-2025 $79.53M $50.81M $580.69M 730.2% $1.44 $-20.18M
Q4-2024 $94.92M $44.55M $-265.54M -279.74% $-0.6 $-234.88M
Q3-2024 $95.35M $41.06M $-455.26M -477.44% $-1.56 $-418.31M

What's going well?

Revenue is growing, and the net loss is much smaller than last quarter. The company is not burdened by debt costs, and share dilution is minimal.

What's concerning?

Operating expenses are growing much faster than sales, and gross margins are shrinking. The core business is deeply unprofitable, and earnings are affected by large 'other' income, making the true performance hard to judge.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $453.44M $2.3B $3.42B $-1.13B
Q2-2025 $581.35M $1.98B $3.04B $-1.06B
Q1-2025 $697.94M $1.63B $1.81B $-181.51M
Q4-2024 $836.2M $1.6B $2.42B $-820.18M
Q3-2024 $253.02M $921.85M $1.65B $-729.39M

What's financially strong about this company?

The company owns a lot of physical assets and has no risky goodwill or intangibles. Debt is all long-term, so there’s no immediate repayment pressure.

What are the financial risks or weaknesses?

Shareholder equity is deeply negative, cash is falling fast, and the company has a history of big losses. With more debt than cash and no profits, survival is at risk if things don’t improve.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-146.66M $131.78M $-254.36M $-5.32M $-127.9M $-122.84M
Q2-2025 $-936.8M $34M $-119.61M $-31.77M $-117.38M $-87.28M
Q1-2025 $580.69M $-40.6M $-93.46M $-4.2M $-138.25M $-129.02M
Q4-2024 $-184.79M $13.8M $-28.8M $598.17M $583.18M $-14.95M
Q3-2024 $-455.26M $5.71M $-31.24M $182.22M $156.7M $-25.34M

What's strong about this company's cash flow?

Operating cash flow improved a lot this quarter, showing the core business can generate cash. The company is not taking on new debt or diluting shareholders with new shares.

What are the cash flow concerns?

Heavy capital spending is causing big cash burn, and the company is relying on working capital changes that may not last. With no cash returned to shareholders and a shrinking cash balance, more funding will likely be needed soon.

Q1 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Core Scientific, Inc. Tranche 2 Warrants's financial evolution and strategic trajectory over the past five years.

+ Strengths

Core Scientific benefits from substantial physical infrastructure, strong power access, and proven expertise in running large fleets of high‑density computing hardware. It has demonstrated the ability to secure major, long‑term AI hosting contracts and to raise significant capital when needed. The pivot toward AI and high‑performance computing aligns the business with powerful secular demand trends, and its proprietary management software provides a layer of operational differentiation. Recent liquidity improvements give it some breathing room to pursue this strategy.

! Risks

At the same time, the financial picture is fragile: persistent large losses, deeply negative equity, and rising debt levels point to elevated solvency risk if performance does not improve. Cash generation is inconsistent, and free cash flow is mostly negative, leaving the company reliant on external financing. Competitive and execution risks around the AI/HPC pivot are high, especially as larger and financially stronger rivals push into the same space. Legacy exposure to crypto markets and energy‑intensive operations adds further regulatory, environmental, and market volatility risks.

Outlook

Overall, Core Scientific appears to be in the midst of a high‑stakes transition from a capital‑intensive, volatile mining business toward a potentially more stable but fiercely competitive AI and high‑performance computing infrastructure model. The long‑term opportunity is considerable if the company can fully utilize its sites with profitable AI/HPC contracts and bring costs under control. However, the current financial condition leaves little margin for error, and outcomes are likely to be binary over time—either a successful repositioning that stabilizes the balance sheet, or continued strain if the pivot falls short of expectations. Monitoring margin trends, debt levels, contract wins, and the evolution of the AI hosting segment will be crucial for understanding how this story develops.